- Revoss Mineralized Cortical/Cancellous Bone Allograft with 250-1000µm particle size, human tissue allograft is used primarily by oral surgeons and periodontists for dental bone regeneration and implant site preparation
Uses
- Dental Implant Prep:
- Building up the jawbone to safely anchor dental implants
- Socket Preservation:
- Filling the extraction site immediately after a tooth extraction to prevent bone collapse
- Alveolar Ridge Augmentation:
- Expanding or thickening the bony ridge of the jaw
- Periodontal Defects:
- Treating bone loss around natural teeth caused by advanced gum disease
- Sinus Elevations:
- Elevating the sinus floor to create sufficient bone depth for upper jaw implants
Features
- 50/50 Mineralized Blend:
- Combines equal parts cortical (dense, structural) and cancellous (spongy, porous) human bone powder
- 250-1000µm Particle Size:
- Optimized grain size for easy packing into small dental bone voids
- Micro Dosage (0.25cc):
- Packaged in a compact 0.25cc volume, minimizing waste for single, small-site extractions or minor defect repairs
- Strict Regulatory Standards:
- Sourced and processed in the USA following strict American Association of Tissue Banks (AATB) standards and FDA regulations (21 CFR Part 1271)
- Extended Shelf Life:
- Offers a long-term stable shelf life for convenient inventory storage
Benefits
- Dual-Action Bone Regeneration:
- The cancellous bone component provides a highly porous framework that accelerates cellular attachment and neovascularization while concurrently, the cortical component offers density and structural stability while the body heals
- High Biocompatibility:
- Because it is a 100% human allograft, the patient's body readily recognizes, resorbs, and replaces the material with healthy, natural host bone over time
- Patient Safety:
- Rigorous donor screening and validated tissue-cleaning protocols virtually eliminate the risk of disease transmission
- Cost Efficiency:
- The small 0.25cc quantity allows practitioners to open only what is needed for micro-grafts, lowering per-procedure overhead costs
